Mad Money 11/21/25 | Audio Only

Here's a comprehensive summary of the provided YouTube video transcript:

Key Concepts

• Market Dynamics Shift: Traditional Thanksgiving week rallies are no longer guaranteed due to algorithmic trading.
• Economic Indicators: Focus on retail sales, PPI, pending home sales, and their impact on Fed rate decisions.
• Sector Analysis: Insights into technology (Zoom, Dell, HP, Zscaler, Texas Instruments), retail (Kohl's, Best Buy, Dick's Sporting Goods, Burlington Stores), industrials (John Deere), pharmaceuticals (AstraZeneca, Pfizer), real estate (Realty Income), and cosmetics (Oddity, e.l.f. Beauty).
• Investment Strategies: Emphasis on high-quality dividend stocks for stability, identifying compelling value in beaten-down stocks, and understanding "tells" to spot market bottoms.
• Federal Reserve Policy: The influence of Fed President John Williams' comments on interest rate cut expectations.
• Company-Specific Analysis: Detailed breakdowns of individual company performance, outlook, and investment recommendations.

Market Outlook and Thanksgiving Week

Jim Cramer begins by noting a significant shift in market behavior. Historically, the week of Thanksgiving saw a predictable rally as sellers took a vacation. However, this is no longer the case due to the dominance of algorithmic trading ("machines"). These machines operate solely on metrics and gauges, disregarding holidays and human sentiment. Consequently, investors cannot rely on a traditional Thanksgiving week rally and must treat the week like any other, with data points and earnings being scrutinized from Monday onwards.

Economic Data and Federal Reserve Policy

• Monday: The week starts with Zoom Communications reporting earnings. Cramer expresses skepticism about Zoom's long-term prospects against Microsoft Teams but anticipates a decent quarter and potential acquisition talks.
• Tuesday: This day is highlighted as particularly important due to key economic data releases, exacerbated by a government shutdown.
  • September Retail Sales Report: This delayed report is expected to show weak numbers, which Cramer views positively as it strengthens the case for Federal Reserve rate cuts.
  • Interest Rate Expectations: The market reacted positively to comments from New York Fed President John Williams, suggesting he is on board with lowering rates, leading to an increase in the odds of a rate cut.
  • Producer Price Index (PPI): A potential spike in PPI, possibly due to tariffs, could indicate higher inflation, counteracting the positive impact of weak retail sales on bond prices and yields.
  • Pending Home Sales Data: Expected to be "dreadful," this data point is crucial because housing turnover significantly drives sales and profits across various industries. The current low turnover (lowest in 40 years) is seen as a drag on the economy. Weak pending home sales are expected to provide the Fed with an "excuse" to cut rates in December.

Key Earnings Reports and Company Analysis

Tuesday:

• Kohl's: Expected to have a decent, not terrible, quarter.
• Best Buy: Likely to be okay, potentially impacted by higher interest rates and tariffs, but offset by a PC refresh cycle.
• Dick's Sporting Goods: Could be "insanely good" due to its acquisition of Foot Locker and a strong lineup of brands like Nike, New Balance, Hoka, and On.
• Analog Devices: Cramer expresses concern due to its exposure to the weak Internet of Things (IoT) and industrial semiconductor markets. He believes the stock is not worth buying but suggests considering Texas Instruments if Analog Devices reports a good quarter.
• Dell Technologies: The betting is that Dell will stumble due to rising semiconductor costs. Cramer is not buying this narrative, believing Michael Dell can manage commodity sourcing effectively. He anticipates strong performance in the data center and enterprise segments and recommends owning the stock ahead of the quarter.
• HP: Cramer believes HP is "genuinely hostage to commodity prices" and will struggle to meet its numbers, despite a recent stock increase.
• Zscaler: Despite the cybersecurity sector being "a dog of late," Cramer predicts Zscaler will report record-breaking results, suggesting it's a buy. The entire cybersecurity group is seen as offering value.
• Abercrombie & Fitch: Described as a "total crapshoot" and not for the faint of heart.
• Burlington Stores: While the other "big three" off-price retailers (TGX and Ross Stores) reported terrifically, Burlington is considered the weakest of the three.

Wednesday:

• John Deere: The stock is described as "made of Teflon." Farming is a necessary business, and government subsidies can benefit farmers during bad harvests, leading to spending on farm equipment. Cramer believes investors can buy shares after the quarter without missing significant upside.

Stock Recommendations and Investment Themes

High-Quality Dividend Stocks: In a volatile market, Cramer advocates for high-quality dividend stocks offering yields north of 5% as a defensive strategy.

• Enbridge: A Canadian pipeline company with a vast network for crude oil and natural gas.
  • Key Points: Transports 30% of North American crude oil and 20% of U.S. natural gas. Offers a dividend yield of over 5.6%. Less sensitive to commodity prices and more to volumes. Benefits from increased oil production. Predictable business with a strong customer base. Potential for growth from natural gas plants powering data centers and export terminals.
  • Recommendation: Cramer sees it as a top choice for yield, offering downside protection and a long-term growth story.
• Pfizer: A big pharma titan with a 6.9% yield.
  • Key Points: Seen as a "bond equivalent" due to limited share price appreciation. Acquisitions like CGEN (cancer specialist) and Nertk (migraine treatment) and the recent $7 billion acquisition of Metsura (GOP-1 weight loss drugs) are intended to offset patent expirations. Sells at less than 8 times earnings. Generates $15 billion in free cash flow, sufficient to cover the dividend.
  • Recommendation: Controversial due to its lack of recent performance, but Cramer believes it's near a breakout and can navigate its tricky period.
• Realty Income (O): A real estate investment trust (REIT) with a 5.7% yield, known for monthly dividends.
  • Key Points: Owns ~15,500 commercial properties leased to retail and industrial clients. Has raised its dividend four times this year. Occupancy rate at 98.7% with a strong rent recapture rate. Tenants are primarily grocery, convenience, dollar stores, and home improvement stores, which sell necessities. No single tenant accounts for more than 3.3% of rent.
  • Recommendation: Cramer views the recent pullback as a buying opportunity, calling it a "sleep at night stock" with a safe, high monthly yield.

Cosmetics Player Oddity:

• Background: Oddity Tech, a direct-to-consumer cosmetic stock, reported a strong quarter, leading to a significant stock surge. However, the broader market's rollover and subsequent pullbacks have impacted its performance.
• Cramer's View: He believes investors are getting the "terrific quarter for free" and that it's a compelling buying opportunity. He acknowledges his past calls on the stock were not entirely accurate, citing insider selling and a large bond offering that diluted its pristine balance sheet.
• Recent Performance: Despite a strong earnings beat and raise, the stock fell due to high expectations and a run-up into earnings.
• Key Drivers:
  • Il Makiage: Performing well with double-digit growth, especially international sales, with a target of $1 billion in sales by 2028.
  • Spoiled Child: Expected to cross $225 million in revenue this year.
  • Methodic (Method IQ): A new "medical telehealth platform" for customized, high-efficacy skincare treatments based on AI-powered diagnosis. Addresses unmet needs in dermatology (acne, eczema, hyperpigmentation). This is a significant development, requiring substantial investment.
• Financials: Raised full-year forecast with all major lines above expectations. Fourth-quarter revenue outlook is strong, though earnings guidance was slightly light.
• Valuation: The stock is trading at less than 18 times this year's earnings and 17 times next year's estimates, which Cramer considers cheap.
• Recommendation: Cramer, despite past miscalls, finds the fundamentals incredible and the stock significantly cheaper than before, making it a compelling value.

Other Stock Discussions:

• Palantir Technologies: Cramer is a buyer, acknowledging it's a "wild trader" but has confidence in CEO Alex Karp.
• Goldman Sachs' Acquisition of Excel Sports Management: Cramer expresses confusion and a lack of enthusiasm for this move, stating it doesn't seem to be in Goldman's "sweet spot."
• Costco: While acknowledging its lackluster stock performance recently, Cramer reminds viewers of its long-term strength. He notes its high P/E ratio (44 times earnings) compared to the broader market and suggests buying at current levels, especially under $900.
• e.l.f. Beauty Supply: Cramer is hesitant to recommend, citing tariff issues and high short interest, fearing a significant downside if he were to call it a buy at current levels.
• The Trade Desk: Cramer is hesitant to go against hyperscalers like Amazon, which is a large position in his trust, even though he respects CEO Jeff Green.
• Open Door Technologies: Cramer is not a believer until the company starts making money, despite its stock's current run.
• Poet Technologies: Cramer cannot recommend due to excessive losses and the end of the "magical investing era."
• Biohaven: Cramer has a personal deal related to a drug invented with a doctor, but he believes the stock appears "very low." He discloses his potential conflict of interest.
• Metzler Toledo International: Described as a "very poorly covered company" but a "very good company." Cramer feels people should focus on it, but it's not promotional.

AstraZeneca's Investment in the U.S.

• Context: Pharmaceutical companies are making significant manufacturing and R&D commitments in the U.S., partly due to President Trump's tariff threats and a desire to maintain innovation leadership.
• AstraZeneca's Commitment: The Anglo-Swedish pharma giant committed $50 billion to U.S. production and R&D by 2030.
• Maryland Expansion: A $2 billion investment in Maryland includes expanding an existing biologics manufacturing facility and building a new state-of-the-art facility for new molecule development for clinical trials.
• Job Creation: Approximately 2600 jobs will be created over the next five years during the construction period.
• CEO Pascal Soriot's Perspective:
  • Highlights the significant investment and excitement around the new facilities.
  • Emphasizes the company's commitment to innovation and addressing tough diseases, particularly in breast cancer, where they have a strong portfolio and have shown overall survival benefits in triple-negative breast cancer.
  • Discusses the high risk and cost associated with drug development, noting their success rate.
  • Explains the "most favored nation" agreement with the President, aiming to reduce U.S. drug costs without destroying the industry, by rebalancing prices with other wealthy countries.
  • Mentions the upcoming NYSE listing in February to increase visibility and accessibility for U.S. investors.
  • The stock has performed well, up 15% over the last year.

How to Spot a Bottom in the Market

Cramer shares his methodology for identifying market bottoms, developed over years of experience.

• S&P Oscillator: A proprietary measure of buying and selling pressure from Market Edge.
  • Mechanism: Zero is equilibrium. +5 indicates exuberance (trim positions), +10 is a sell signal. -5 indicates oversold conditions and a rebound is due.
  • Application: Cramer saw a -3.73 reading, indicating the opening bounce would be "wrong" due to insufficient selling pressure. He waited for a subsequent swoon to reach the oversold territory.
• "Tells": Named after Ricky Jay, these are subtle indicators of potential market moves.
  • Example: Yesterday, the "tells" were Micron and SanDisk, not Nvidia. These plain vanilla tech storage players plummeted, signaling a potential downturn before Nvidia gave up.
  • Application: Cramer watched these stocks for signs of reversal to confirm a bottom.
• Bitcoin: Its freefall and subsequent U-turn are crucial indicators.
• Soft Goods and Drug Stocks: Their rallying indicates a broader market recovery.
• Transports (especially Rails): A strong transport sector is a positive sign.
• Round-the-Clock Trading: The need to monitor overnight trading (e.g., Bitcoin, key tech stocks) starting as early as 3:15 a.m.
• Crescendo Bottom: A situation where extreme negativity leads to a simultaneous capitulation by all investors, creating an ideal buying opportunity.
• Role of Fed Comments: John Williams' comments on rate cuts can significantly alter market sentiment, potentially preventing a "crescendo bottom" if hopes for cuts are dashed by strong economic data.
• Confirmation: Cramer looks for transports and soft goods to lead the rally, followed by Bitcoin and then major tech stocks like Nvidia.
• Personal Experience: Cramer emphasizes that this is not "hocus pocus" but a practiced methodology from his hedge fund days, detailed in his book "Real Money." He believes stocks "talk" and can be understood by listening.

Conclusion

The market has fundamentally changed, with algorithmic trading dictating price action over traditional seasonal patterns. Investors must remain vigilant, analyze economic data closely, and understand company-specific fundamentals. Cramer advocates for a balanced approach, considering high-quality dividend stocks for stability and identifying undervalued companies like Oddity. His methodology for spotting market bottoms, based on indicators like the S&P Oscillator and "tells," provides a framework for navigating volatility. Ultimately, Cramer reiterates that there is always a bull market, and with the right strategy and understanding, investors can achieve long-term success.